Share the article

Antibiotic resistance is a complex issue involving many actors, such as patients, prescribers, providers, the pharmaceutical industry and politicians. In a way, all of us have contributed to the current situation, but who is responsible for taking actions to solve the problem of access vs. excess and how can it be done?

Reflection point

Please reflect upon the following questions:

  • Who is responsible for the fair distribution of antibiotics worldwide?
  • How do we find distribution models that increase access to effective antibiotics while reducing excess use in low- and middle-income countries?

© Uppsala University